Indivior Pharmaceuticals (INDV) Cost of Revenue (2024 - 2026)
Indivior Pharmaceuticals' Cost of Revenue came in at $50 million for Q2 2026, down 3.8% from $52 million a year earlier but up 25.0% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Cost of Revenue (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Cost of Revenue of $240 million, up 14.3% year-over-year; for FY2025, it came in at $246 million, up 6.5% from FY2024.
- Cost of Revenue has increased in each of the last four years, with a four-year compound annual growth rate of 18.0% (FY2021 to FY2025).
- Going back by year, Cost of Revenue was $231 million in FY2024 (+32.8%), $174 million in FY2023 (+15.2%), $151 million in FY2022 (+18.9%) and $127 million in FY2021.
- The five-year range for quarterly Cost of Revenue is $38 million (Q1 2024) to $83 million (Q3 2025).
- Year-over-year, Cost of Revenue increased in three of the last six quarters, with growth averaging 5.7%.
- Business Quant data shows INDV's Cost of Revenue at $40 million (Q1 2026), $67 million (Q4 2025) and $83 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn | 50.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.00 Mn |
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 67.00 Mn |
| Sep 30, 2025 | 83.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | 48.00 Mn |
| Sep 30, 2024 | 66.00 Mn |
| Jun 30, 2024 | 79.00 Mn |
| Mar 31, 2024 | 38.00 Mn |
API Access
Indivior Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();